HUTCHMED (HCM) News Today $13.24 -0.17 (-1.27%) As of 12:39 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HCM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period D. E. Shaw & Co. Inc. Trims Position in HUTCHMED (China) Limited (NASDAQ:HCM)D. E. Shaw & Co. Inc. decreased its position in HUTCHMED (China) Limited (NASDAQ:HCM - Free Report) by 55.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 41,543 shares of the company's stock after selling 51,734 shares during the quaMay 27 at 3:31 AM | marketbeat.comBNP Paribas Financial Markets Trims Stock Position in HUTCHMED (China) Limited (NASDAQ:HCM)BNP Paribas Financial Markets cut its stake in shares of HUTCHMED (China) Limited (NASDAQ:HCM - Free Report) by 32.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 39,643 shares of the company's stock aftMay 26 at 3:22 AM | marketbeat.comHUTCHMED (NASDAQ:HCM) Downgraded to "Buy" Rating by Wall Street ZenWall Street Zen downgraded HUTCHMED from a "strong-buy" rating to a "buy" rating in a research report on Thursday.May 24, 2025 | marketbeat.comHUTCHMED to Present Promising Oncology Data at 2025 ASCO MeetingMay 22, 2025 | tipranks.comHUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual MeetingMay 22, 2025 | globenewswire.comJane Street Group LLC Grows Position in HUTCHMED (China) Limited (NASDAQ:HCM)Jane Street Group LLC grew its stake in shares of HUTCHMED (China) Limited (NASDAQ:HCM - Free Report) by 54.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 97,470 shares of the company's stock after acquiring an additional 34,473 sharesMay 22, 2025 | marketbeat.comHUTCHMED Successfully Passes All Resolutions at 2025 AGMMay 13, 2025 | tipranks.com18,102 Shares in HUTCHMED (China) Limited (NASDAQ:HCM) Acquired by Marshall Wace LLPMarshall Wace LLP acquired a new stake in HUTCHMED (China) Limited (NASDAQ:HCM - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 18,102 shares of the company's stock, valued at approximately $261,000. Other institutional investorsMay 7, 2025 | marketbeat.comHUTCHMED (NASDAQ:HCM) Trading 3.9% Higher - Here's WhyHUTCHMED (NASDAQ:HCM) Shares Up 3.9% - Should You Buy?April 30, 2025 | marketbeat.comHUTCHMED (NASDAQ:HCM) Shares Down 5.7% - Should You Sell?HUTCHMED (NASDAQ:HCM) Trading Down 5.7% - Time to Sell?April 27, 2025 | marketbeat.comRenaissance Technologies LLC Has $2.72 Million Holdings in HUTCHMED (China) Limited (NASDAQ:HCM)Renaissance Technologies LLC lifted its position in HUTCHMED (China) Limited (NASDAQ:HCM - Free Report) by 18.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 188,539 shares of the company's stock aApril 27, 2025 | marketbeat.comHUTCHMED (NASDAQ:HCM) Shares Gap Up - Time to Buy?HUTCHMED (NASDAQ:HCM) Shares Gap Up - Time to Buy?April 24, 2025 | marketbeat.comHUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2025April 23, 2025 | globenewswire.comHUTCHMED Completes Enrollment for Savolitinib Phase II Study in Gastric CancerApril 21, 2025 | tipranks.comHUTCHMED Completes Patient Enrollment of a Phase II Registration Study of Savolitinib in Gastric Cancer in ChinaApril 21, 2025 | globenewswire.comHUTCHMED (NASDAQ:HCM) Shares Gap Down - What's Next?HUTCHMED (NASDAQ:HCM) Shares Gap Down - Time to Sell?April 17, 2025 | marketbeat.comHUTCHMED (NASDAQ:HCM) Trading Up 6.9% - Time to Buy?HUTCHMED (NASDAQ:HCM) Trading Up 6.9% - Should You Buy?April 16, 2025 | marketbeat.comBristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM TrialApril 14, 2025 | businesswire.comHUTCHMED (NASDAQ:HCM) Shares Gap Up - What's Next?HUTCHMED (NASDAQ:HCM) Shares Gap Up - Still a Buy?April 11, 2025 | marketbeat.comHUTCHMED (NASDAQ:HCM) Shares Up 8.3% - Here's WhyHUTCHMED (NASDAQ:HCM) Shares Up 8.3% - Here's What HappenedApril 10, 2025 | marketbeat.comHUTCHMED (NASDAQ:HCM) Shares Gap Down - Should You Sell?HUTCHMED (NASDAQ:HCM) Shares Gap Down - Here's WhyApril 9, 2025 | marketbeat.comHUTCHMED (NASDAQ:HCM) Trading Up 7.5% - Here's WhyHUTCHMED (NASDAQ:HCM) Shares Up 7.5% - What's Next?April 3, 2025 | marketbeat.comHUTCHMED (China) Limited (NASDAQ:HCM) Shares Sold by Schroder Investment Management GroupSchroder Investment Management Group lowered its stake in shares of HUTCHMED (China) Limited (NASDAQ:HCM - Free Report) by 5.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,768,941 shares of theApril 3, 2025 | marketbeat.comEdgewise Therapeutics Sees Meaningful HCM Treatment Gains With EDG-7500 In Phase 2 StudyApril 2, 2025 | benzinga.comHUTCHMED (NASDAQ:HCM) Shares Gap Up - Here's WhyHUTCHMED (NASDAQ:HCM) Shares Gap Up - Here's What HappenedMarch 28, 2025 | marketbeat.comHUTCHMED (NASDAQ:HCM) Shares Gap Down - Time to Sell?HUTCHMED (NASDAQ:HCM) Shares Gap Down - Here's What HappenedMarch 26, 2025 | marketbeat.comTerrestrial Energy to Become First Publicly Traded Molten Salt Nuclear Reactor Developer Through Combination with HCM II Acquisition Corp.March 26, 2025 | globenewswire.comHUTCHMED (China) Limited (NASDAQ:HCM) Shares Sold by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. reduced its stake in HUTCHMED (China) Limited (NASDAQ:HCM - Free Report) by 38.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 30,109 shares of the company'sMarch 23, 2025 | marketbeat.comHUTCHMED (NASDAQ:HCM) Rating Increased to Buy at StockNews.comStockNews.com upgraded shares of HUTCHMED from a "hold" rating to a "buy" rating in a research note on Friday.March 22, 2025 | marketbeat.comHUTCHMED (NASDAQ:HCM) Stock Price Down 5.7% - Time to Sell?HUTCHMED (NASDAQ:HCM) Stock Price Down 5.7% - Should You Sell?March 22, 2025 | marketbeat.comHutchmed says NDA for Tazverik granted conditional approval in ChinaMarch 21, 2025 | markets.businessinsider.comHUTCHMED Announces NMPA Conditional Approval for TAZVERIK® (tazemetostat) for the Treatment of Relapsed or Refractory Follicular LymphomaMarch 21, 2025 | globenewswire.comAnalysts Are Bullish on These Healthcare Stocks: Dermata Therapeutics (DRMA), HUTCHMED (HCM)March 21, 2025 | markets.businessinsider.comHUTCHMED and Innovent report success in renal cancer studyMarch 20, 2025 | investing.comIntended Retirement of Independent Non-executive Directors and changes of composition of board committeesMarch 20, 2025 | globenewswire.comHutchmed reports FY24 EPS 22c vs. 59c last yearMarch 20, 2025 | markets.businessinsider.comHutchmed sees FY25 Oncology/Immunology revenue $350M-$450MMarch 20, 2025 | markets.businessinsider.comHUTCHMED’s Savolitinib Shows Promising Results in Lung Cancer TrialsMarch 19, 2025 | tipranks.comHUTCHMED Highlights Savolitinib SAVANNAH Phase II and Other Data at European Lung Cancer Congress 2025March 19, 2025 | globenewswire.comHUTCHMED (China) Limited: HUTCHMED Reports 2024 Full Year Results and Provides Business UpdatesMarch 19, 2025 | finanznachrichten.deHUTCHMED Reports 2024 Full Year Results and Provides Business UpdatesMarch 19, 2025 | markets.businessinsider.comHutchmed spikes after cancer trial win despite 2024 revenue missMarch 19, 2025 | msn.comHUTCHMED (China) Limited (HCM) Q4 2024 Earnings Call TranscriptMarch 19, 2025 | seekingalpha.comHUTCHMED (China) Limited 2024 Q4 - Results - Earnings Call PresentationMarch 19, 2025 | seekingalpha.comHUTCHMED Reports 2024 Full Year Results and Provides Business UpdatesMarch 19, 2025 | globenewswire.comInnovent and HUTCHMED Jointly Announce that the FRUSICA-2 Phase 2/3 Study of Sintilimab and Fruquintinib Combination Has Met Its Primary Endpoint in Advanced Renal Cell Carcinoma in ChinaMarch 18, 2025 | prnewswire.comHUTCHMED and Innovent’s Combination Therapy Shows Promise in Advanced Renal Cell CarcinomaMarch 18, 2025 | tipranks.comHUTCHMED and Innovent Jointly Announce that the FRUSICA-2 Phase II/III Study of Fruquintinib and Sintilimab Combination Has Met its Primary Endpoint in Advanced Renal Cell Carcinoma in ChinaMarch 18, 2025 | globenewswire.comHUTCHMED (China) (LON:HCM) shareholders have earned a 3.7% CAGR over the last three yearsMarch 10, 2025 | finance.yahoo.comHUTCHMED Announces that it has Completed Enrollment of a Phase II Registration Study of Fanregratinib (HMPL-453) for Intrahepatic Cholangiocarcinoma in ChinaMarch 6, 2025 | globenewswire.com Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address HCM Media Mentions By Week HCM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCM News Sentiment▼0.891.03▲Average Medical News Sentiment HCM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCM Articles This Week▼73▲HCM Articles Average Week Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ROIV News RVMD News BPMC News BBIO News ELAN News VRNA News TLX News GRFS News TGTX News LEGN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HCM) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThe biggest threat isn’t ChinaWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share HUTCHMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HCM Stock Free HCM Stock Alerts